Nephrocare Health Services Ltd. IPO Details – Price, Date, GMP & Analysis
Nephrocare Health Services Ltd. IPO Overview
Company Overview
Nephrocare Health Services Ltd., incorporated in 2010, provides comprehensive dialysis care through a network of clinics in India and select international markets. The company offers various services, including diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy. As of September 30, 2025, Nephrocare operated 519 clinics, including the world's largest dialysis clinic in Uzbekistan, and served 29,281 patients with 2,885,450 dialysis treatments during Fiscal 2025. The company has strategic partnerships with several established hospital chains to operate in-house dialysis centers.
IPO Timeline
Timeline information will be updated when available.
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 26.82x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 24.77x | Oversubscribed |
| RII (Retail Individual Investors) | 2.36x | Oversubscribed |
| Total Subscription | 14.08x | Oversubscribed |
Last updated: Dec 12, 2025, 06:21 PM
Financial Information
Financial information will be available when the company releases its DRHP.
Strengths & Risks Analysis
Key Risks
Potential challenges and risk factors
- Capital-intensive model requiring continuous funding support.
- Quality control challenges across a large clinic network.
- Dependent on kidney disease prevalence and policy support.
- Increasing competition from hospitals and local players.
- High operating costs may pressure profitability margins.
IPO Details
Detailed information will be available closer to the IPO launch date.
Key Dates
